MP Article List

1. [Sutton, NEJM, 2012, pay for performance programs, risk adjusted absolute mortality, pneumonia]
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21. [Goran, Global Public Health, 2012, high fructose corn syrup, diabetes,
20%]
22. [Volkow, AM J Psychiatry, 2007, obesity, addiction, hypothalamus]
23. [Post,Archives of Int Med, 11, Physician, NHNE survey, Perception]
24. [Arterburn, Obesity Surgery, 2012, RYGB, 35%, 8.3 years]
25. [neilson,nejm, 12,statin, cellular proliferation, cancer related mortality]
26.
27.
28. [Bischoff-Ferari, NEJM, 2012, Vit D, 800, cox proportional hazardsregression analysis ]
29. [Ogutu, BMC, Proceedings, 2011, Random Forests, Gradient Boosting, support vector machine]
30. [Hermayer, JCEM, 2012, renal transplant, delayed graft function, rejection ]
31. [Tobias, Acrhives Int Med, 2012, GDM, 7 fold, 57%]
32. [Stanford, JCI, 2012, BAT, Insulin stimulated glucose uptake, IL-6 ]
33. [Cohen, Surgery Obesity Related Disease, 2012, duodenel-jejeunal bypass, waist circumference, insulin sensitivity ]
34. [Burton, JCEM, 2012, 11C-Metomidate PET-CT, aldosteronoma, SUV 1.25:1]
35. [Nixon, Arch Otolaryngol Head Neck Surg, 2012, intermediate-risk PTC, nodal metastases, DSS 100%]
36. [Keating,Journal of the National Cancer Institute,12, VA Health Systems, Tumor Board, stage-specific recommended care]
37. [Akin, Clinical endocrinology, 12, metformin, pigment epithelim derived factor, insulin resistance]
38. [ADA, Diabetes Care, 12, 140, 130, 80]
39. [Bangalore, JAMA, 12, Beta blockers, CAD, recent MI]
40. [Grunnet, JCEM, 12, MT, hepatic insulin resistance, total body fat]
41. [Chen, Int J of Impotence research, 12, losartan, cavernous local renin-angiotensin system, severe ED ]
42. [Koren, Lancet, 12, PCSK9, LDL, 50.9%]
43. [Lyles, Diabetes Care, 12, food insecurity, diabetes self management, 0.38%]